Form 4: ANI Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold shares to cover tax obligations related to vesting restricted stock.
Summary
- On February 29, 2024, Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, disposed of 1,173 shares of common stock.
- The shares were sold at a price of $67.67 per share.
- This transaction was to cover tax obligations related to the vesting of 3,039 shares of restricted stock.
- Following the transaction, Cook directly owns 60,231 shares of ANI Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. An executive selling shares to cover taxes is a normal occurrence and doesn't necessarily reflect a positive or negative outlook on the company.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction. It's common for executives to sell shares to cover tax obligations when restricted stock vests.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Date of transaction: Sale of 1,173 shares of common stock. |
| 03/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.